- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| TREACE MEDICAL CONCEPTS Aktie jetzt für 0€ handeln | |||||
| Do | Treace Medical Concepts, Inc.: Treace Announces First Surgical Case with the HyperPlate XM Dynamic Compression Locking Implant System | 2 | GlobeNewswire (USA) | ||
| 20.05. | TREACE MEDICAL CONCEPTS, INC. - 8-K, Current Report | 1 | SEC Filings | ||
| 08.05. | TREACE MEDICAL CONCEPTS, INC. - S-8, Securities to be offered to employees in employee benefit plans | - | SEC Filings | ||
| 08.05. | Treace Medical: Aktie steigt nach übertroffenen Quartalszahlen trotz Umsatzminus | 1 | Investing.com Deutsch | ||
| 08.05. | Treace Medical Concepts GAAP EPS of -$0.28 beats by $0.03, revenue of $47.2M beats by $1.15M | 3 | Seeking Alpha | ||
| 08.05. | Treace Medical Concepts, Inc.: Treace Medical Concepts Reports First Quarter 2026 Financial Results | 1.218 | GlobeNewswire (Europe) | PONTE VEDRA, Fla., May 08, 2026 (GLOBE NEWSWIRE) -- Treace Medical Concepts, Inc. ("Treace" or the "Company") (NasdaqGS: TMCI), a medical technology company driving a fundamental shift in the surgical... ► Artikel lesen | |
| 08.05. | TREACE MEDICAL CONCEPTS, INC. - 10-Q, Quarterly Report | 1 | SEC Filings | ||
| 08.05. | TREACE MEDICAL CONCEPTS, INC. - 8-K, Current Report | 1 | SEC Filings | ||
| 24.04. | Treace Medical Concepts, Inc.: Treace to Report First Quarter 2026 Financial Results on May 8, 2026 | 2 | GlobeNewswire (USA) | ||
| 09.04. | Stifel belässt Treace Medical auf 'Halten' mit Kursziel von 3 US-Dollar | 3 | Investing.com Deutsch | ||
| 09.04. | Stifel maintains Hold on Treace Medical stock, $3 target unchanged | 1 | Investing.com | ||
| 09.04. | TREACE MEDICAL CONCEPTS, INC. - 8-K, Current Report | - | SEC Filings | ||
| 07.04. | Treace Medical Concepts, Inc.: Treace Announces First Surgical Cases with the SuperBite Compression Screw System | 285 | GlobeNewswire (Europe) | PONTE VEDRA, Fla., April 07, 2026 (GLOBE NEWSWIRE) -- Treace Medical Concepts, Inc. ("Treace" or the "Company") (NasdaqGS: TMCI), a medical technology company driving a fundamental shift in the surgical... ► Artikel lesen | |
| 27.02. | Treace Medical signals 2026 revenue target of $200M-$212M while expanding comprehensive bunion solutions | 4 | Seeking Alpha | ||
| 27.02. | Treace Medical Concepts GAAP EPS of -$0.15 in-line, revenue of $62.5M beats by $0.63M | 2 | Seeking Alpha | ||
| 27.02. | Treace Medical Concepts: EPS verfehlt Schätzungen - Umsatz besser als erwartet | 2 | Investing.com Deutsch | ||
| 27.02. | Treace Medical Concepts Q4 Earnings Summary & Key Takeaways | 1 | Benzinga.com | ||
| 27.02. | TREACE MEDICAL CONCEPTS, INC. - 10-K, Annual Report | - | SEC Filings | ||
| 27.02. | TREACE MEDICAL CONCEPTS, INC. - 8-K, Current Report | 1 | SEC Filings | ||
| 27.02. | Treace Medical Concepts, Inc.: Treace Medical Concepts Reports Fourth Quarter and Full-Year 2025 Financial Results | 1.019 | GlobeNewswire (Europe) | PONTE VEDRA, Fla., Feb. 27, 2026 (GLOBE NEWSWIRE) -- Treace Medical Concepts, Inc. ("Treace" or the "Company") (NasdaqGS: TMCI), a medical technology company driving a fundamental shift in the surgical... ► Artikel lesen |
1 2 Weiter >>
31 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| SERNOVA BIOTHERAPEUTICS | 0,090 | -10,00 % | Sernova Biotherapeutics, Inc.: Sernova Biotherapeutics Receives FDA Orphan Drug Designation for Autologous Islet Transplantation for Prevention of Diabetes Due to Total Pancreatectomy | TORONTO and BOSTON, June 17, 2026 (GLOBE NEWSWIRE) -- Sernova Biotherapeutics Inc. ("Sernova" or the "Company") (TSX: SVA) (OTC: SEOVF) (FSE/XETRA: PSHO), a leading regenerative medicine company focused... ► Artikel lesen | |
| SONOMA PHARMACEUTICALS | 2,350 | -100,00 % | Sonoma Pharmaceuticals, Inc. - 8-K, Current Report | ||
| TANDEM DIABETES | 12,500 | -0,79 % | Deutsche Bank initiates Tandem Diabetes stock with hold rating | ||
| VERU | 3,040 | +2,70 % | Top Biotech Gainers: VERU Teams Up With NVO, ABSI On Watch, ALVO Resubmits BLAs To FDA... | REYKJAVIK (dpa-AFX) - Thursday's top gainers include Veru, following a Novo Nordisk collaboration; Health Catalyst, following a divestment of its revenue workflow and analytics software business... ► Artikel lesen | |
| SENSEONICS | 5,450 | -2,68 % | Senseonics Holdings, Inc. Reports Fourth Quarter and Full Year 2025 Financial Results | Generated Q4 revenue of $14.3 million, an increase of 72% year-over-year Received CE Mark approval for commercialization of Eversense 365 in Europe Launched first Eversense 365 AID system integration... ► Artikel lesen | |
| TEMPEST THERAPEUTICS | 1,260 | +0,80 % | Tempest Therapeutics, Inc. - 8-K, Current Report | ||
| STAAR SURGICAL | 25,280 | +0,24 % | STAAR SURGICAL CO - 8-K, Current Report | ||
| VIRIDIAN THERAPEUTICS | 15,300 | -0,65 % | XFRA 1S1: WIEDERAUFNAHME/RESUMPTION | FOLGENDE(S) INSTRUMENT(E) WIRD/ WERDEN WIEDER IN DEN HANDEL AUFGENOMMEN MIT FOLGENDEM TRADING SCHEDULE.THE FOLLOWING INSTRUMENT(S) IS/ARE RESUMED TRADING WITH FOLLOWING TRADING SCHEDULE:INSTRUMENT NAME... ► Artikel lesen | |
| SINTX TECHNOLOGIES | 1,910 | -4,02 % | SINTX Technologies, Inc.: SINTX Technologies Announces Receipt of More Than $3.2 Million in Contract Manufacturing Purchase Orders | SALT LAKE CITY, Utah, June 22, 2026 (GLOBE NEWSWIRE) -- SINTX Technologies, Inc. (NASDAQ: SINT) ("SINTX" or the "Company"), a leader in advanced silicon nitride ceramics and advanced material technologies... ► Artikel lesen | |
| VYOME | 2,140 | -1,38 % | Mitschrift des Earnings Call: Vyome Holdings weist für Q1 2026 eine starke Cash-Position aus | ||
| VIVANI MEDICAL | 1,030 | +5,10 % | Vivani Medical: Lake Street startet Coverage mit Kaufempfehlung und sieht erhebliches Kurspotenzial | ||
| STEREOTAXIS | 1,592 | -0,38 % | Stereotaxis, Inc.: Stereotaxis Reports 2026 First Quarter Financial Results & Business Updates | Proprietary robotically-navigated MAGiC catheter received U.S. FDA approval in January and is now being utilized at multiple sites across the United States as well as EuropeSynchrony digital operating... ► Artikel lesen | |
| VICARIOUS SURGICAL | 1,980 | +1,02 % | Vicarious Surgical Reports First Quarter 2026 Financial Results | WALTHAM, Mass., April 30, 2026 (GLOBE NEWSWIRE) -- Vicarious Surgical Inc. ("Vicarious Surgical" or the "Company") (OTCQB: RBOT), a next-generation robotics technology company seeking to improve lives... ► Artikel lesen | |
| VIEMED HEALTHCARE | 9,150 | +1,67 % | Reportable, Inc.: Stonegate Capital Partners Updates Coverage on Viemed Healthcare, Inc. (VMD) 1Q26 | Dallas, Texas--(Newsfile Corp. - May 12, 2026) - Viemed Healthcare, Inc. (NASDAQ: VMD). Stonegate Capital Partners Updates Coverage on Viemed Healthcare, Inc. (NASDAQ: VMD). Viemed's 1Q26 results... ► Artikel lesen | |
| VIVOS THERAPEUTICS | 0,460 | +14,32 % | Vivos Therapeutics, Inc: Vivos Therapeutics and Streeterville Extend Timeframe of Strategic Financing Agreement and Reaffirm Commitment to Convert Debt Into Common Stock and Perpetual Preferred Equity | LITTLETON, Colo., June 22, 2026 (GLOBE NEWSWIRE) -- Vivos Therapeutics, Inc. ("Vivos" or the "Company") (NASDAQ: VVOS), a leading medical device and healthcare services company focused on the treatment... ► Artikel lesen |
Das Unternehmen TREACE MEDICAL CONCEPTS INC kann der Branche Gesundheitswesen zugeordnet werden. Die relative Kursveränderung beträgt aktuell +12,97 % bei einem Aktienkurs von 4,530 Euro.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und sowie Kurse und Daten von ARIVA.DE AG.
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu TREACE MEDICAL CONCEPTS INC finden Sie auf Wallstreet Online.